| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | N15SW1DIV8 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Activin receptor type-2B antagonist | PubMed |
| Primary Target | |
|---|---|
| activin A receptor type 2B |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Myositis, Inclusion Body | 3 | D018979 | ClinicalTrials |
| Pulmonary Disease, Chronic Obstructive | 2 | D029424 | ClinicalTrials |
| Cachexia | 2 | D002100 | ClinicalTrials |
| Sarcopenia | 2 | D055948 | ClinicalTrials |
| Diabetes Mellitus, Type 2 | 2 | D003924 | ClinicalTrials |
| Muscular Atrophy | 2 | D009133 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1356922-05-8 |
| ChEMBL | CHEMBL3137353 |
| FDA SRS | N15SW1DIV8 |
| Guide to Pharmacology | 8086 |
CONTENTS